Nautilus Biotechnology, Inc.
NAUT- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001808805
No open-market purchases or sales by Nautilus Biotechnology, Inc. insiders were filed in the last 90 days; 93 institutions reported holding it in 13F filings for Q2 2026, worth $93.7M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Nautilus Biotechnology, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 82 | 83 | +1 |
| Shares | 56.0M | 57.5M | +1.48M (+2.6%) |
| Value | $243.5M | $154.7M | −$88.8M (−36.5%) |
New holders (22)
Institutions that held Nautilus Biotechnology, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Crown Advisors Management, Inc. | 250,000 | $672.0K | 0.62% |
| Nuveen Asset Management, LLC | 205,767 | $553.0K | 0.00% |
| Rhumbline Advisers | 65,231 | $175.0K | 0.00% |
| Brighton Jones LLC | 44,244 | $119.0K | 0.01% |
| New York State Common Retirement Fund | 34,200 | $92.0K | 0.00% |
| Deutsche Bank AG | 22,536 | $61.0K | 0.00% |
| American International Group, Inc. | 22,309 | $60.0K | 0.00% |
| Voya Investment Management LLC | 20,754 | $56.0K | 0.00% |
| California State Teachers Retirement System | 20,383 | $55.0K | 0.00% |
| Jump Financial, LLC | 20,000 | $54.0K | 0.00% |
| Invesco Ltd. | 19,408 | $52.0K | 0.00% |
| SG Americas Securities, LLC | 19,207 | $52.0K | 0.00% |
| Marshall Wace, LLP | 11,500 | $30.0K | 0.00% |
| STRS Ohio | 11,100 | $29.0K | 0.00% |
| Amalgamated Bank | 6,035 | $16.0K | 0.00% |
| Legal & General Group Plc | 4,020 | $11.0K | 0.00% |
| Ameritas Investment Partners, Inc. | 3,575 | $9.00K | 0.00% |
| The PNC Financial Services Group, Inc. | 642 | $2.00K | 0.00% |
| Point72 Hong Kong Ltd | 906 | $2.00K | 0.00% |
| Sargent Bickham Lagudis LLC | 425 | $1.00K | 0.00% |
| Eagle Bay Advisors LLC | 337 | $907 | 0.00% |
| Credit Suisse AG | 57 | $0 | 0.00% |
Sold out (21)
Institutions that held Nautilus Biotechnology, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Sphera Funds Management Ltd. | 840,000 | $3.65M |
| Franklin Resources Inc | 458,732 | $1.99M |
| Pura Vida Investments, LLC | 244,698 | $1.06M |
| ExodusPoint Capital Management, LP | 137,826 | $598.0K |
| Ensign Peak Advisors, Inc | 134,695 | $585.0K |
| Sender Co & Partners, Inc. | 73,960 | $321.0K |
| Sciencast Management LP | 63,529 | $283.0K |
| Bank of Montreal | 62,000 | $270.0K |
| Squarepoint Ops LLC | 42,626 | $185.0K |
| Mirabella Financial Services LLP | 36,340 | $158.0K |
| Balyasny Asset Management LLC | 29,212 | $127.0K |
| CAPROCK Group, Inc. | 24,790 | $108.0K |
| Simplex Trading, LLC | 18,890 | $81.0K |
| Y-Intercept (Hong Kong) Ltd | 16,106 | $70.0K |
| Principal Financial Group Inc | 14,061 | $61.0K |
| Schonfeld Strategic Advisors LLC | 13,211 | $57.0K |
| Fifth Lane Capital, LP | 10,200 | $44.0K |
| Rockefeller Capital Management L.P. | 2,000 | $8.00K |
| UBS Group AG | 804 | $3.00K |
| Ovata Capital Management Ltd | 600 | $3.00K |
| State of Wyoming | 497 | $2.00K |